Molecular Devices

Join the discussion
Using spheroid models to develop relevant high-throughput assays with quantitative endpoints

Produced in collaboration with Corning and Cellular Dynamics International

Date: Thursday, November 3, 2016

Time: 8:00 AM PDT | 10:00 AM CET | 11:00 AM EDT | 3:00 PM GMT


Grischa Chandy, Ph.D. and Oksana Sirenko, Ph.D. |  Molecular Devices

Mark Rothenberg, Ph.D | Corning Life Sciences

Michael Hancock, Ph.D | Celluar Dynamics International


Join us to learn about:

  • Selecting products and solutions for implementation of 3D spheroid models
  • Testing efficacy of anticancer drugs using cancer spheroids
  • Analyzing phenotypic characterization of compound treatments on iPSC-derived hepatocyte spheroids
  • Assessing drug effects on cardiomyocyte physiology using human iPSC-derived cardiac spheroids

To register for the webinar, please fill out the form below.

By submitting your details, you confirm that you have reviewed and agree with the Molecular Devices Privacy Policy, and that you understand your privacy choices as they pertain to your personal data as provided in the Privacy Policy under “Your Privacy Choices”.

About the presenters

Grischa Chandy, Senior Product Marketing and Applications Manager | Molecular Devices

Grischa Chandy is Senior Product Marketing and Applications Manager for Cellular Imaging at Molecular Devices, LLC.  Grischa’s scientific background is in cell biology, physiology and biophysics.  He has used and developed imaging techniques and technologies throughout his career starting with his doctoral work at U.C. Irvine, his postdoc at U.C. Berkeley as well as Research Scientist position at Stanford University.

Grischa has been with Molecular Devices for 10 years, driving launches of the ImageXpress Micro –XL and ImageXpress Micro-XLS systems, MetaXpress Software versions 3 onwards and most recently the launch of the ImageXpress Micro Confocal system and ImageXpress Micro 4 system.

Oksana Sirenko, Research Scientist, Marketing | Molecular Devices

Oksana Sirenko earned her Ph.D. in Biochemistry from the Biochemistry Research Institute, Academy of Sciences in Ukraine. For over 15 years, she has worked as a Research Scientist in cell-based assay development, drug discovery and drug development in several pharma and biotech companies, including Novartis, Bayer, and Fibrogen. At Molecular Devices she is focused on assay development using high-content imaging systems and other instruments to develop methods for cell-based disease modelling and toxicity research. 

Mike Hancock, Senior Technical Application Scientist | Cellular Dynamics International

Mike Hancock earned his Ph.D. in Biochemistry from the Medical College of Wisconsin. For over 13 years, he has worked as a cell-based assay development scientist in pharma and biotech. In his current role, Mike is a Senior Technical Application Scientist at Cellular Dynamics International where he helps to characterize and develop ways to utilize the growing palette of human iPSC-derived cell types, including: astrocytes, cardiomyocytes, hepatocytes, macrophages, neurons, and skeletal myoblasts.

Mark Rothenberg, Manager Scientific Training and Education | Corning Life Sciences

Mark Rothenberg graduated from Emory University with his PhD in Cell and Developmental Biology. Over the past 25 years Mark has held positions in both Academia and industry where he has developed an expertise in the areas of assay development, cell culture, and cell culture scale-up.  Mark has been with Corning Life Sciences for eight and a half years. Prior to his current position as Manager Scientific Training and Education he worked and led the applications team.